Yea-Hung Chen1, Willi McFarland, Henry F Raymond, Hyman M Scott, Eric Vittinghoff, Travis C Porco. 1. *Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA; †Center for Public Health Research, San Francisco Department of Public Health, San Francisco, CA; ‡Bridge HIV, San Francisco Department of Public Health, San Francisco, CA; §Center for AIDS Prevention Studies, University of California, San Francisco, San Francisco, CA; ‖Department of Medicine, University of California, San Francisco, San Francisco, CA; and ¶Francis I Proctor Foundation for Research in Ophthalmology, University of California, San Francisco, San Francisco, CA.
Abstract
BACKGROUND: Despite continued reductions in the number of HIV cases reported among San Francisco men who have sex with men (MSM) and the HIV-prevention potential offered by pharmaceutical tools such as pre-exposure prophylaxis (PrEP), there are uncertainties, particularly given reported decreases in consistent condom use. A key uncertainty is what groups of MSM should be targeted. This study estimates the distribution of behavioral patterns before infection among San Francisco MSM newly infected with HIV in 2014. METHODS: We used a novel modeling approach. The approach uses estimates from the National HIV Behavioral Surveillance System for MSM, the Medical Monitoring Project, 2 trials of PrEP, and a meta-analysis of per-act risks of HIV infection. RESULTS: The modeling study suggests that 76% of newly HIV-infected MSM in 2014 were individuals with no discernible strategy in the 6 months before infection: that is, they had condomless receptive anal intercourse with one or more partners not perceived to be HIV uninfected. An estimated 7% of newly infected MSM were serosorters before infection. CONCLUSIONS: Prevention efforts in San Francisco must reach HIV-uninfected MSM with no discernible behavioral strategy, a group that constitutes 8% of HIV-uninfected MSM in the city. Our study suggests that if all HIV-uninfected, San Francisco MSM with no discernible strategy had been on PrEP in 2014, there would have been 70% fewer HIV infections among San Francisco MSM. Uncertainty analysis suggests that PrEP's impact may be maximized by encouraging PrEP persistence and concomitant reductions in sexual risk behaviors.
BACKGROUND: Despite continued reductions in the number of HIV cases reported among San Francisco men who have sex with men (MSM) and the HIV-prevention potential offered by pharmaceutical tools such as pre-exposure prophylaxis (PrEP), there are uncertainties, particularly given reported decreases in consistent condom use. A key uncertainty is what groups of MSM should be targeted. This study estimates the distribution of behavioral patterns before infection among San Francisco MSM newly infected with HIV in 2014. METHODS: We used a novel modeling approach. The approach uses estimates from the National HIV Behavioral Surveillance System for MSM, the Medical Monitoring Project, 2 trials of PrEP, and a meta-analysis of per-act risks of HIV infection. RESULTS: The modeling study suggests that 76% of newly HIV-infected MSM in 2014 were individuals with no discernible strategy in the 6 months before infection: that is, they had condomless receptive anal intercourse with one or more partners not perceived to be HIV uninfected. An estimated 7% of newly infected MSM were serosorters before infection. CONCLUSIONS: Prevention efforts in San Francisco must reach HIV-uninfected MSM with no discernible behavioral strategy, a group that constitutes 8% of HIV-uninfected MSM in the city. Our study suggests that if all HIV-uninfected, San Francisco MSM with no discernible strategy had been on PrEP in 2014, there would have been 70% fewer HIV infections among San Francisco MSM. Uncertainty analysis suggests that PrEP's impact may be maximized by encouraging PrEP persistence and concomitant reductions in sexual risk behaviors.
Authors: Hyman M Scott; Eric Vittinghoff; Risha Irvin; Darpun Sachdev; Albert Liu; Marc Gurwith; Susan P Buchbinder Journal: J Acquir Immune Defic Syndr Date: 2014-01-01 Impact factor: 3.731
Authors: Susan P Buchbinder; David V Glidden; Albert Y Liu; Vanessa McMahan; Juan V Guanira; Kenneth H Mayer; Pedro Goicochea; Robert M Grant Journal: Lancet Infect Dis Date: 2014-03-07 Impact factor: 25.071
Authors: Rebecca J Guy; Tim Spelman; Mark Stoove; Carol El-Hayek; Jane Goller; Christopher K Fairley; David Leslie; Bk Tee; Norman Roth; Andrew E Grulich; Margaret E Hellard Journal: Sex Health Date: 2011-09 Impact factor: 2.706
Authors: Susan P Buchbinder; Eric Vittinghoff; Patrick J Heagerty; Connie L Celum; George R Seage; Franklyn N Judson; David McKirnan; Kenneth H Mayer; Beryl A Koblin Journal: J Acquir Immune Defic Syndr Date: 2005-05-01 Impact factor: 3.731
Authors: Snigdha Vallabhaneni; Xin Li; Eric Vittinghoff; Deborah Donnell; Christopher D Pilcher; Susan P Buchbinder Journal: PLoS One Date: 2012-10-03 Impact factor: 3.240
Authors: Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill Journal: Lancet Date: 2015-09-09 Impact factor: 79.321